nicotinic ACh agonists (Novo Nordisk)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namenicotinic ACh agonists (Novo Nordisk)
Drug Alias NameNNC-90-0270
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors modulatorsMuscarinic acetylcholine receptor agonists
TargetsMuscarinic acetylcholine receptorNicotinic receptors
Therapy Area/IndicationsDrug-induced extrapyramidal reactionsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsDrug-induced extrapyramidal reactionsAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A